Chefaa Secures $5.25 Million
The funding will help the Egypt based pharma delivery platform expand in Saudi Arabia.
The patient-centric pharmacy platform Chefaa has secured $5.25 million in funding from new and existing investors, according to a statement. [1]
The funding was co-led by Newtown Partners (South Africa) and Global Brain (Japan), with GMS Capital Partners LLC (US), Verod-Kepple Africa Ventures (Nigeria), as well as M3, Inc. (Japan).
Founded in 2017 by Doaa Aref and Rasha Rady, Chefaa connects more than one million monthly active users to more than 1,100 pharmacies across Egypt and KSA and has +800K mobile app downloads.
The investment comes after the platform's successful launch of operations in KSA where Chefaa is now operating in 8 Saudi cities. Moreover, this strategic funding will support Chefaa’s efforts to scale all models designed to digitize the supply chain, and empower industry stakeholders, which inevitably reflects on users’ experience and boosts compliance with treatment.
Chefaa is a tech-enabled company of healthcare and the supply chain in Africa and the Middle East. It is designed to empower patients to live healthier lives by providing comprehensive essential healthcare solutions for both individuals and entities, aiming to be the one-stop-health solution for an end-to-end healthcare experience.
